J

Jefferies

Global investment banking and capital markets

Compliance Analyst

Full-Time
No salary listed
Entry
Bachelor's
Toronto, ON, Canada
In Person

About the job

Requirements
  • Bachelor’s degree in Finance, Economics, Business, Political Science, Law, Accounting, Computer Science, Data Analytics, or a related field.
Responsibilities
  • Support the day-to-day operations of the Compliance function across regulatory, advisory, monitoring, and surveillance activities.
  • Assist in reviewing policies, procedures, and internal controls to ensure alignment with applicable regulatory requirements and industry best practices.
  • Assist with transaction monitoring, communications surveillance, trade surveillance, or other risk-based monitoring activities as applicable.
  • Help prepare internal compliance reports, management updates, regulatory filings, and audit or examination materials.
  • Monitor regulatory developments and assist in assessing their potential impact on the business.
  • Work with Legal, Risk, Operations, Technology, Finance, and front-office teams to support compliance initiatives.
  • Maintain accurate records of compliance reviews, approvals, exceptions, escalations, and remediation efforts.
  • Assist in compliance testing, risk assessments, control reviews, and internal investigations as needed.
  • Support training initiatives by helping prepare materials, track completion, and identify areas for employee education.
  • Contribute to process improvements, automation initiatives, and compliance technology enhancements.
Desired Qualifications
  • Internship exposure to compliance, legal, risk, operations, internal audit, financial crime, regulatory reporting, or control functions.
  • Familiarity with securities regulations, AML/KYC requirements, sanctions compliance, market abuse rules, data privacy, or fintech regulatory frameworks.
  • Experience with compliance platforms, surveillance tools, case management systems, CRM tools, or data analytics software.
  • Basic knowledge of SQL, Python, Tableau, Power BI, or other data analysis tools is a plus.

About the company

Jefferies is a global, full‑service investment banking and capital markets firm that helps investors, companies, and governments with advisory services, sales and trading, research, and wealth and asset management. It uses a worldwide network of more than 40 offices to deliver market insights and financial solutions to clients. Its products include advisory services for mergers and restructurings, capital markets execution, securities research, and portfolio management for individuals and institutions. The goal is to guide clients through financial markets, raise capital, and grow wealth across geographies and asset classes.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

New York City, New York

Founded

1854

Get referred to Jefferies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The SMBC joint venture launches in January 2027, opening Japan equities and ECM.
  • Q3 2026 advisory revenue rose 25% and equity underwriting jumped 69%.
  • Jefferies raised buyback authorization to $250 million and kept a $0.40 dividend.

What critics are saying

  • Asset-management revenue fell 55% sequentially in Q3 2026 after First Brands and Radiant World losses.
  • Western Alliance sued Jefferies in March 2026 over a $126.4 million unpaid loan.
  • Another First Brands-style scandal would cripple Jefferies' reputation and trading-client trust.

What makes Jefferies unique

  • SMBC now owns about 20%, giving Jefferies a powerful Japanese distribution alliance.
  • Jefferies posted record Q3 2026 investment-banking revenue of $1.33 billion.
  • Its equities franchise generated a quarterly record $626 million in Q3 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

Wellness Program

Company News

Yahoo Finance
Sep 30th, 2026
Jefferies tips three biotech stocks with blockbuster potential worth $15B+ in peak sales

Jefferies has identified three undervalued biotechnology stocks with strong commercial prospects despite challenging macroeconomic conditions. Delphia Therapeutics' oral psychedelic DT120 has produced three positive Phase III datasets for major depressive disorder and generalized anxiety disorder. Jefferies estimates $1.5 billion or more in peak sales per indication, implying a $9 billion valuation against the current $5 billion market cap. Axsome Therapeutics' Auvelity is approved for major depressive disorder and Alzheimer's agitation. Management's peak sales guidance of $8 billion for Auvelity suggests significant upside. BridgeBio Pharma is positioned to launch four blockbuster oral medications. Attruby could reach $3-4 billion in US peak sales, whilst three additional billion-dollar products will launch in 2027. The firm noted rising interest rates are pressuring small and mid-cap biotech companies, potentially shifting investor focus toward late-stage and commercial-stage names.

Yahoo Finance
Sep 30th, 2026
Jefferies picks Molbio Diagnostics as top India med-tech buy with INR1,600 target

Jefferies has named Molbio Diagnostics its top pick in India's medical supplies sector, initiating coverage with a Buy rating and a price target of INR1,600. The brokerage projects revenue compound annual growth rate of 22% and profit after tax CAGR of 47% through FY26-29E. Founded in 2000, Molbio has developed the Truenat platform, an ultra-portable molecular diagnostics system that represents 86% of FY26 sales. The platform, built after 13 years of research, supports testing for 30 diseases and is patent-protected in over 100 countries. Jefferies expects margin expansion of approximately 830 basis points, driven by rising test-kit capacity utilisation and the scaling of Molbio's Optrascan platform to 11% of sales by FY29E.

Seeking Alpha
Sep 30th, 2026
Jefferies: Asset Management issues remain A drag following Q3 2026 earnings.

Jefferies: Asset Management issues remain A drag following Q3 2026 earnings. 4.39K Followers Summary. * Jefferies Financial Group posted strong Investment Banking and Capital Markets results in Q3 2026, offsetting significant weakness in Asset Management. * JEF's Asset Management unit suffered a 55% sequential and 52% YoY revenue decline, driven by repeated credit events and reputational setbacks. * Despite group revenues of $2.2B and EPS of $1.08 beating expectations, persistent asset management issues justify the stock's discounted 0.9x book value. * I maintain a 'Hold' rating on JEF, as ongoing credit concerns and weak investor sentiment limit the risk-return appeal for long-term investors. As I've covered some months ago, Jefferies Financial Group (JEF) has reported a positive operating performance in recent quarters, but some issues related to private credit have resulted in negative investor sentiment toward

The Edge Media Group
Sep 29th, 2026
Jefferies stung by soured bets at asset-management unit

Jefferies stung by soured bets at asset-management unit. 29 Sep 2026, 09:07 pm (Sept 29): Jefferies Financial Group Inc's asset-management unit revenue slumped more than 50% in the fiscal third quarter, sending shares down as the bank grapples with fallout from tumultuous investments. Net revenue in that business totalled US$85.6 million (RM349 million) in the three months through August, down from almost US$177 million in the same period a year earlier, according to a statement late Monday. That business has been dealing with soured bets on First Brands Group and Radiant World that the firm was exposed to through Leucadia Asset Management's Point Bonita fund. Shares of Jefferies dropped 1.1% in early New York trading, extending this year's decline to more than 25%. "We remain confident in the long-term outlook for the business as we continue to reposition the platform by reducing capital allocated to certain existing funds consistent with the strategy we outlined last fall when we announced our intent to acquire and fund a 50% interest in Hildene," chief executive officer Richard Handler and president Brian Friedman said in the statement. In 2025, Jefferies agreed to buy a 50% stake in Hildene Holding Co, a credit-focused asset manager that the bank had had a strategic relationship with for years. The firm's asset-management woes overshadowed a record quarter for Jefferies' stock traders and investment bankers. Equity-trading revenue surged 29% from a year earlier to US$626 million, boosted by cash and electronic trading as well as the prime services business that works with hedge funds. Revenue at the investment-banking business rose 17% to US$1.3 billion. That was driven by a 25% gain in the advisory unit and a 69% increase in the equity-underwriting business. In recent months, Radiant World has come under scrutiny amid allegations of fraud. Jefferies' exposure to Radiant World was less than US$300 million, Bloomberg previously reported. Fixed income. Jefferies' fixed-income trading business also had a tougher quarter, hit by a sluggish market that drove a 26% decrease in net revenue. Still, equity trading was "robust," even if questions are arising about how sustainable it can be, according to Vital Knowledge's Adam Crisafulli. The quarter was OK, he said. "Not amazing, not horrible." Earnings per share totalled US$1.08 in the period, surpassing the US$1 average estimate of analysts in a Bloomberg survey. Jefferies is the first of the major US banks to post third-quarter results, setting a benchmark for Wall Street firms that report in October. The results offer a look into how investment-banking businesses have held up despite market volatility. "We are very optimistic about the balance of 2026 and our momentum heading into 2027, supported by the breadth and strength of our current backlog and new business activity," Handler and Friedman said in the statement. The bank's quarter is also a positive sign for Wall Street's other equity-trading desks, many of which had already started hinting at how good the quarter was shaping up. Bank of America Corp. CEO Brian Moynihan said equity trading climbed in the quarter through the middle of September, while Goldman Sachs Group Inc's David Solomon said equity trading has remained "very strong." Fixed-income trading, however, has been softer in some parts of Wall Street. Bank of America has cautioned that revenue in the business was down and bouncing around. Uploaded by Magessan Varatharaja

Finnews Network
Sep 29th, 2026
Jefferies surpasses profit estimates on strong dealmaking.

Jefferies surpasses profit estimates on strong dealmaking. Jefferies Financial (JEF.N) has exceeded third-quarter profit estimates, propelled by strong performance in its advisory and stock underwriting businesses. The New York-based investment bank, which advises on deals, underwrites stock sales, and operates trading desks and an asset management business, reported profit attributable to shareholders of $260.6 million, or $1.08 per share, for the three months ended August 31. This comfortably surpassed the average analyst estimate of $1 per share, according to LSEG data. The company's investment banking revenue saw a significant 17% jump, reaching $1.33 billion, underpinned by record advisory business performance and robust equity underwriting. Revenue from its capital markets segment, encompassing Jefferies' trading desks, also climbed 11% to $802 million, driven by record equities trading. These results offer an early indication of broader investment banking trends on Wall Street, arriving ahead of major US banks' earnings reports in coming weeks, and align with a global dealmaking environment that has exceeded $4 trillion this year. Despite the overall strong showing, Jefferies' asset management business faced headwinds. Fees and investment return revenue in this division shrank considerably to $34 million, down from $84 million a year earlier. This decline reflects weaker performance across several fund strategies, notably Point Bonita, which held exposure to the bankrupt auto-parts supplier First Brands. Looking forward, CEO Richard Handler and President Brian Friedman expressed optimism for 2026 and momentum into 2027, citing strong backlog and new business activity, while also affirming confidence in the long-term outlook for the asset management platform. However, the firm's shares were down 1.5% in extended trading, contributing to an approximate 24% decline this year.